Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

The post Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125% appeared first on 24/7 Wall St.. Quick Read Morning Brew Daily hosts argue Eli Lilly’s (LLY) “Mounjaro economy” is replacing the “Ozempic economy,” as Eli Lilly controls 60% of the GLP-1 market. Lilly’s Q1 2026 revenue hit $19.80 billion, up 55.5% YoY, with Mounjaro surging 125% to $8.66 billion as the company raises full-year guidance to $82.0B-$85.0B. Lilly’…